October 26, 2020

Volume X, Number 300

Advertisement

October 26, 2020

Subscribe to Latest Legal News and Analysis

October 23, 2020

Subscribe to Latest Legal News and Analysis

USPTO Patent Fees To Increase Oct. 2

Highlights

  • USPTO patent fees will soon be increasing across the board

  • This is part of a biennial review process, but the agency also took another look in light of COVID-19

  • Business and individuals impacted may want to respond before the Oct. 2 effective date, to benefit from the lower price

The United States Patent and Trademark Office (USPTO) recently announced that it would be increasing most of its patent fees, effective Oct. 2, 2020.  

The fees have increased between 4 percent and 25 percent, with the average fee increase between 5 percent and 7 percent.  

Additionally, the USPTO added a new fee for non-DOCX filings, which is effective on Jan. 1, 2022. And, the USPTO discontinued four fees, including three patent service fees.  

In light of these upcoming fee increases, affected businesses and individuals may want to respond and pay the accompanying fee before the Oct. 2 effective date, to benefit from the lower price. 

These changes have been in discussion since 2017 – the agency typically reviews fees biennially – and the USPTO has issued reports and guidance and solicited public comment along the way; taking the impact of the COVID-19 pandemic into consideration as well. 

For ease of reference, you can view the full schedule of fee changes. 

© 2020 BARNES & THORNBURG LLPNational Law Review, Volume X, Number 262
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement
Advertisement

About this Author

Jessamine G. Pilcher IP Lawyer Barnes & Thornburg Law Firm
Associate

Jessamine’s IP focus is in the biomedical, biologics, pharmaceutical, life sciences, and education sectors. A registered patent agent who has worked for a university, she has been on the other side of the table and is able to put herself in the shoes of her business, scientist and inventor clients and assist them with obstacles in the patent process.

Jessamine drafts provisional and non-provisional applications, including Patent Cooperation Treaty (PCT) applications with the U.S. Patent and Trademark Office (USPTO), ranging from medical device, vaccine adjuvants, cancer therapies...

317-231-6419
Advertisement
Advertisement